US versions - for Intl. English version, see Resources
A helpful tool for progressive systems of care
Systems of care implementing LUCAS together with a comprehensive approach to resuscitation have shown increased ROSC rates3, 4, 5, 6, 7, 8, 9, 24, 25as well as improved survival with good neurological outcomes5, 7, 10, 25compared to historical data.
Multiple case studies describe the value of the LUCAS device for individual patient outcomes.
Pre-hospital sudden cardiac arrest patients
In-hospital sudden cardiac arrest patients
More flow to the brain and heart with the LUCAS device
Increased flow to the brain
LUCAS has shown to create more blood flow to the brain both in humans and experimental studies compared to manual CPR.11, 12
Sustain coronary perfusion pressures
LUCAS chest compressions have shown sustain coronary perfusion
pressures over the 15mmHg threshold, as well as coronary artery blood flow (TIMI III)13, 14
increase of mean average ETCO2 value compared to manual CPR15
High-quality CPR with less interruptions
Delivery of high-quality CPR is vital for patient outcomes.
The LUCAS device delivers safe and effective chest compressions with Guidelines-consistent depth of 5.3 cm / 2.1 inches and rate of 102 per minute*
* LUCAS 3, version 3.1 can be configured for depth and rate
LUCAS compression/s first and after several minutes of CPR
Manual compression/s first and after several minutes of CPR
LUCAS allows for defibrillation during ongoing compressions
LUCAS allows for application of the defibrillation electrodes outside the suction cup. The LUCAS device does not need to be stopped when delivering the shock (only stop when doing the rhythm analysis).1
US version - for Intl. English version, see Resources
More flow time with LUCAS
LUCAS has documented chest compression fractions of up to 93%, leading
to significantly more flow time compared to manual CPR.16, 17, 18, 19, 20
Bridge to definitive care
Some cardiac arrest patients will not respond to CPR and defibrillation alone.
LUCAS allows for lifesaving interventions (such as PCI and ECMO/ECPR) by providing consistent compressions on the way to and during these advanced life-saving therapies.
Facilitates cardio-cerebral perfusion during prolonged CPR
Numerous documented saves with good neurological outcomes after consistent, high-quality LUCAS compressions for 1, 2, 3, 4+ hours.
Buys time to find and treat reversible causes
From 8.2% historical survival to 50% survival with good neurological function implementing a progressive approach to take appropriate patients from the field to the hospital for advanced life-saving interventions, such as ECMO and PCI.21
LUCAS buys time and allows for the simultaneous diagnosis and treatment of reversible causes, e.g. coronary occlusion, pulmonary emboli, intoxication or accidental hypothermia.
Saves lives in the cath lab
Using LUCAS during a continued coronary intervention, 25% vs. historical 10% of sudden cardiac arrest patients who did not respond to normal advanced resuscitation efforts, could be saved with good neurological outcome.22 This despite prolonged CPR durations of up to 50 minutes.
Life-saving PCI during LUCAS chest compressions leads to significant improvements in ROSC in cardiac arrest patients with persistent VF or non-shockable rhythms.23
â€œThe LUCAS device is a very easy implementation to help improve patient survival.
These are patients who could survive but donâ€™t because the quality of CPR drops after the first responders.â€
Dr AP Shah, University of Chicago Medicine, Chicago, IL, US. Read more
Take the next step
Want to talk to your sales representative? Please tell us a little about yourself and we’ll connect you with your local representative.